James J. Yeh, M.D.

Present Positions:

  • Program Director, Fellowship in Hematology and Medical Oncology, Harbor-UCLA Medical Center
  • Chief, Division of Hematology and Medical Oncology, Department of Medicine, Harbor-UCLA Medical Center
  • Associate Clinical Professor, David Geffen School of Medicine at the University of California, Los Angeles

Specialty:

  • Medical Oncology and Hematology

Academic Interests:

  • Medical education, mentorship and curriculum development
  • Quality improvement

Committees:

  • Hematology-Oncology Expert Panel, Los Angeles County Department of Health Services
  • Hematology-Oncology Workgroup, Los Angeles County Department of Health Services
  • Chemotherapy Order Sets, Los Angeles County Department of Health Services
  • Genomic Testing in Oncology, Los Angeles County Department of Health Services
  • Diversity, Equity, and Inclusion, Department of Medicine, Harbor-UCLA
  • Intern Selection and Recruitment, Department of Medicine, Harbor-UCLA
  • Pharmacy and Therapeutics, Harbor-UCLA
  • Infusion Clinic and Chemopharmacy Task Force

Recognition and Awards:

  • Kouichi R. Tanaka Distinguished Teaching Award, Attending, Department of Internal Medicine, Harbor-UCLA Medical Center, June 2021
  • Los Angeles Productivity and Quality Top 10 Awards, “Make it a Movie Night with At-Home Chemotherapy”, August 2019
  • First Place, Harbor Internal Medicine Photo Scavenger Hunt, Attending Bracket, June 2019
  • Finalist, Physician-of-the-Year, March 2019
  • Kouichi R. Tanaka Distinguished Teaching Award, Attending, Department of Internal Medicine, Harbor-UCLA Medical Center, June 2014
  • Kouichi R. Tanaka Distinguished Teaching Award, Fellow, Department of Internal Medicine, Harbor-UCLA Medical Center, June 2006

Education:

  • Fellowship in Hematology and Medical Oncology, Harbor-UCLA Medical Center, 2006-2009
  • Kennamer Fellowship in General Internal Medicine, Harbor-UCLA Medical Center, 2005-2006
  • Residency in Internal Medicine, Harbor-UCLA Medical Center, 2002-2005
  • MD, University of California, Los Angeles, 1998-2002

Recent Publications:

  • Chehrazi-Raffle A, Leong S, Ali S, Kim T, Melamed S, Li X, Zengin Z, Meza L, Chawla N, Govindarajan A, Castro D, Mercier B, Ebrahimi H, Dizman N, Tripathy N, Sayegh N, Rock A, Yeh J, Pal SK, Onyshchenko M. Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. Oncologist, July 11, 2023. PMID: 37432304
  • Epistola R, Ho B, Leong S, Ali S, Germono R, Kummerfeldt C, Gutierrez G, Shim J, Lee JM, Yeh J. Applying Lean Kaizen to Improve Timely Computed Tomography Scan Appointments for Oncology Patients in a Safety Net Hospital. JCO Oncology Practice. February 17, 2023. PMID: 36800555
  • Liu J, Kaji AH, Roth KG, Hari DM, Yeh J, Dauphine C, Ozao-Choy J, Chen KT. Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital. Clin Breast Cancer. 2022. PMID: 34474985
  • Salgia, Nicholas; Chehrazi-Raffle, Alexander; Hsu, Joann; Zengin, Zeynep; Salgia, Sabrina; Chawla, Neal; Meza, Luis; Malhotra, Jasnoor; Dizman, Nazli; Muddasani, Ramya; Ruel, Nora; Cianfrocca, Mary; Gong, Jun; Anand, Sidharth; Chiu, Victor; Yeh, J; Pal, Sumanta. Characterizing the relationships between tertiary and community cancer center providers: results from a survey of medical oncologists in Southern California. Cancer Medicine. July 31, 2021. PMID: 34331372
  • Epistola R, Do T, Vankina R, Wu D, Yeh J, Fleischman MW, Lee JM. Immune Thrombocytopenic Purpura (ITP) as an Uncommon Extraintestinal Complication of Crohn’s Disease: Case Vignette and Systematic Literature Review. Case Rep Hematol. 2020. PMID: 32274225
  • Gupta R, Othman T, Uche A, Amanam I, Chen C, Celles L, Lane G, Mei M, Aldoss I, Pullarkat V, Kim P, Yeh J. Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32199763
  • Uche A, Sila C, Tanoura T, Yeh J, Bhowmick N, Posadas E, Figlin R, Gong J. Brain Complete Response to Cabozantinib Prior to Radiation Therapy in Metastatic Renal Cell Carcinoma. Case Rep Urol. 2019. PMID: 30906615
  • Satyananda V, Gupta R, Hari DM, Yeh J, Chen KT. Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed? Gastroenterol Res Pract. 2019. PMID: 30863442
  • Uche A, Vankina R, Gong J, Cho M, Yeh J, Kim P, Pan K. Capecitabine-induced Hypertriglyceridemia: A Rare but Clinically Relevant Treatment-Related Adverse Event. J Gastrointest Oncol. 2018. PMID: 30603144
  • Nguyen BM, Halprin C, Olimpiadi Y, Traum P, Yeh J, Dauphine C. Core Needle Biopsy Is a Safe and Accurate Initial Diagnostic Procedure for Suspected Lymphoma. Am J Surg. 2014. PMID: 25286777
  • Qing X, Sun N, Yeh J, Yue C, Cai J. Dengue Fever and Bone Marrow Myelofibrosis. Exp Mol Pathol. 2014. PMID: 25016180
  • Chang G, Yeh J. Fulminant Phlegmasia Cerulea Dolens With Concurrent Cholangiocarcinoma and a Lupus Anticoagulant: A Case Report and Review of the Literature. Blood Coagul Fibrinolysis. 2014. PMID: 24553060
  • Uemura M, Huynh R, Kuo A, Antelo F, Deiss R, Yeh J. Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient With HIV Infection. Case Rep Hematol. 2013. PMID: 24073345
  • Yeh J, Uemura M. Hepatocellular Carcinoma. NEJM. 2012. PMID: 22216856

Interests: